NCT02054442 - A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG

Cetuximab

We will perform a randomized phase II study to investigate in first line if the addition of cetuximab to MTX is beneficial, i.e. improvement in the PFS, for the patient.

DRUG

Methotrexate

Trial Locations (8)

Unknown

Medisch Spectrum Twente, Enschede

Medical Centre Leeuwarden, Leeuwarden

Leiden University Medical Center, Leiden

Academisch Ziekenhuis Maastricht, Maastricht

Radboud university medical center, Nijmegen

Erasmus Medical Center, Rotterdam

Medical Centre Haaglanden, The Hague

St. Elisabeth Ziekenhuis, Tilburg